Altimmune (ALT US)

Altimmune, Inc. is a clinical-stage biopharmaceutical company. The Company focuses on the development of novel peptide-based therapeutics for the treatment of obesity, NASH, chronic hepatitis B, and liver diseases. Altimmune serves patients and healthcare professionals worldwide.